| Product Code: ETC13200218 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global C-Reactive Protein Market was valued at USD 1.4 Billion in 2024 and is expected to reach USD 1.9 Billion by 2031, growing at a compound annual growth rate of 8.20% during the forecast period (2025-2031).
The Global C-Reactive Protein (CRP) market is experiencing steady growth due to the rising prevalence of inflammatory diseases and infections worldwide. CRP testing is used extensively in clinical settings to assess inflammation levels and monitor various conditions such as cardiovascular diseases, autoimmune disorders, and infections. The market is driven by increasing awareness about the importance of early diagnosis and monitoring of inflammatory conditions, as well as technological advancements in CRP testing methods. Key players in the global CRP market are investing in research and development activities to introduce innovative products and expand their product portfolios. North America currently dominates the market, followed by Europe and Asia-Pacific. With the growing emphasis on personalized medicine and healthcare, the CRP market is expected to continue its growth trajectory in the coming years.
The Global C-Reactive Protein (CRP) market is witnessing steady growth driven by the increasing prevalence of chronic diseases such as cardiovascular diseases and cancer, leading to a rise in the demand for CRP testing. Technological advancements in CRP testing methods, such as high-sensitivity assays and point-of-care testing, are also contributing to market growth. Furthermore, the growing awareness among individuals regarding the importance of early disease detection and monitoring is creating opportunities for market expansion. The market is also benefiting from the rising adoption of CRP testing in various applications, including diagnosis, prognosis, and monitoring of inflammatory conditions. As the healthcare industry continues to prioritize preventive healthcare measures, the demand for CRP testing is expected to further increase, presenting promising opportunities for market players to innovate and expand their product offerings.
The Global C-Reactive Protein Market faces several challenges, including increasing competition among market players leading to pricing pressures, stringent regulatory requirements for product approval, and the need for continuous technological advancements to stay competitive. Additionally, the market is influenced by factors such as fluctuating healthcare expenditure, reimbursement policies, and the availability of alternative diagnostic methods. Furthermore, the lack of standardization in testing procedures and variations in C-reactive protein levels among individuals pose challenges in accurately interpreting test results. Addressing these challenges requires market players to invest in research and development for innovative products, collaborate with regulatory bodies to streamline approval processes, and educate healthcare professionals about the benefits of C-reactive protein testing for improved patient outcomes.
The global C-Reactive Protein (CRP) market is primarily driven by the increasing prevalence of inflammatory and infectious diseases, such as cardiovascular diseases, arthritis, and bacterial infections. The rising adoption of CRP testing in routine clinical practice for diagnosing and monitoring various diseases is also contributing to market growth. Additionally, the growing awareness among healthcare professionals and patients regarding the importance of early detection and management of inflammatory conditions is fueling the demand for CRP testing. Technological advancements in CRP testing methods, such as high-sensitivity assays and automated platforms, are further boosting market expansion. Moreover, the increasing geriatric population and the rising healthcare expenditure in developing countries are expected to drive the market for CRP testing in the coming years.
Government policies related to the Global C-Reactive Protein Market typically focus on ensuring the accuracy, safety, and quality of diagnostic tests involving C-reactive protein. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in Europe have established guidelines for the approval and monitoring of C-reactive protein tests to ensure their reliability in diagnosing inflammatory conditions and assessing disease progression. These policies aim to protect public health by ensuring that healthcare providers have access to accurate and effective diagnostic tools while also safeguarding patients from inaccurate or misleading test results. Additionally, government initiatives may support research and development efforts in the field of C-reactive protein testing to drive innovation and improve healthcare outcomes.
The Global C-Reactive Protein Market is poised for significant growth in the coming years, driven by the increasing prevalence of inflammatory diseases, cardiovascular diseases, and infections worldwide. The market is expected to expand due to the rising demand for diagnostic tests that can aid in the early detection and monitoring of various health conditions. Technological advancements in healthcare diagnostics, coupled with the growing emphasis on preventive healthcare measures, are likely to further propel market growth. Additionally, the integration of C-reactive protein testing in point-of-care settings and the development of high-sensitivity assays are anticipated to drive market expansion. However, factors such as stringent regulatory requirements and the availability of alternative diagnostic methods may pose challenges to market growth in the future.
In the global C-Reactive Protein market, Asia is expected to witness significant growth due to the rising prevalence of chronic diseases and increasing healthcare expenditure in countries like China and India. North America is likely to dominate the market owing to the presence of established healthcare infrastructure and a high adoption rate of advanced diagnostic technologies. In Europe, the market is driven by the growing geriatric population and increasing awareness about the benefits of early disease detection. The Middle East and Africa region is projected to experience moderate growth due to improving healthcare facilities and rising investments in the healthcare sector. Latin America is anticipated to show steady growth with increasing government initiatives to enhance healthcare services and address the burden of infectious diseases.
Global C-Reactive Protein Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global C-Reactive Protein Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global C-Reactive Protein Market Revenues & Volume, 2021 & 2031F |
3.3 Global C-Reactive Protein Market - Industry Life Cycle |
3.4 Global C-Reactive Protein Market - Porter's Five Forces |
3.5 Global C-Reactive Protein Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global C-Reactive Protein Market Revenues & Volume Share, By Assay Type, 2021 & 2031F |
3.7 Global C-Reactive Protein Market Revenues & Volume Share, By Detection Range, 2021 & 2031F |
3.8 Global C-Reactive Protein Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.9 Global C-Reactive Protein Market Revenues & Volume Share, By Analysis Mode, 2021 & 2031F |
3.10 Global C-Reactive Protein Market Revenues & Volume Share, By End- User, 2021 & 2031F |
3.11 Global C-Reactive Protein Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Global C-Reactive Protein Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global C-Reactive Protein Market Trends |
6 Global C-Reactive Protein Market, 2021 - 2031 |
6.1 Global C-Reactive Protein Market, Revenues & Volume, By Assay Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global C-Reactive Protein Market, Revenues & Volume, By Immunoturbidimetric Assay, 2021 - 2031 |
6.1.3 Global C-Reactive Protein Market, Revenues & Volume, By ELISA, 2021 - 2031 |
6.1.4 Global C-Reactive Protein Market, Revenues & Volume, By Chemiluminescence Immunoassay, 2021 - 2031 |
6.1.5 Global C-Reactive Protein Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global C-Reactive Protein Market, Revenues & Volume, By Detection Range, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global C-Reactive Protein Market, Revenues & Volume, By hs-CRP, 2021 - 2031 |
6.2.3 Global C-Reactive Protein Market, Revenues & Volume, By Conventional CRP, 2021 - 2031 |
6.2.4 Global C-Reactive Protein Market, Revenues & Volume, By cCRP, 2021 - 2031 |
6.3 Global C-Reactive Protein Market, Revenues & Volume, By Disease, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global C-Reactive Protein Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.3.3 Global C-Reactive Protein Market, Revenues & Volume, By Cancer, 2021 - 2031 |
6.3.4 Global C-Reactive Protein Market, Revenues & Volume, By Rheumatoid Arthritis, 2021 - 2031 |
6.3.5 Global C-Reactive Protein Market, Revenues & Volume, By Inflammatory Bowel Disease, 2021 - 2031 |
6.3.6 Global C-Reactive Protein Market, Revenues & Volume, By Endometriosis, 2021 - 2031 |
6.3.7 Global C-Reactive Protein Market, Revenues & Volume, By Lupus, 2021 - 2031 |
6.3.8 Global C-Reactive Protein Market, Revenues & Volume, By Syphilis, 2021 - 2031 |
6.3.9 Global C-Reactive Protein Market, Revenues & Volume, By Inflammatory Diseases, 2021 - 2031 |
6.4 Global C-Reactive Protein Market, Revenues & Volume, By Analysis Mode, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global C-Reactive Protein Market, Revenues & Volume, By Serum, 2021 - 2031 |
6.4.3 Global C-Reactive Protein Market, Revenues & Volume, By Plasma, 2021 - 2031 |
6.4.4 Global C-Reactive Protein Market, Revenues & Volume, By Blood, 2021 - 2031 |
6.5 Global C-Reactive Protein Market, Revenues & Volume, By End- User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global C-Reactive Protein Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.5.3 Global C-Reactive Protein Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.4 Global C-Reactive Protein Market, Revenues & Volume, By Laboratories, 2021 - 2031 |
6.5.5 Global C-Reactive Protein Market, Revenues & Volume, By Assisted Living Healthcare Facilities, 2021 - 2031 |
6.5.6 Global C-Reactive Protein Market, Revenues & Volume, By Home, 2021 - 2031 |
6.6 Global C-Reactive Protein Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global C-Reactive Protein Market, Revenues & Volume, By Kits, 2021 - 2031 |
6.6.3 Global C-Reactive Protein Market, Revenues & Volume, By Reagents, 2021 - 2031 |
7 North America C-Reactive Protein Market, Overview & Analysis |
7.1 North America C-Reactive Protein Market Revenues & Volume, 2021 - 2031 |
7.2 North America C-Reactive Protein Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
7.3 North America C-Reactive Protein Market, Revenues & Volume, By Assay Type, 2021 - 2031 |
7.4 North America C-Reactive Protein Market, Revenues & Volume, By Detection Range, 2021 - 2031 |
7.5 North America C-Reactive Protein Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.6 North America C-Reactive Protein Market, Revenues & Volume, By Analysis Mode, 2021 - 2031 |
7.7 North America C-Reactive Protein Market, Revenues & Volume, By End- User, 2021 - 2031 |
7.8 North America C-Reactive Protein Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8 Latin America (LATAM) C-Reactive Protein Market, Overview & Analysis |
8.1 Latin America (LATAM) C-Reactive Protein Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) C-Reactive Protein Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) C-Reactive Protein Market, Revenues & Volume, By Assay Type, 2021 - 2031 |
8.4 Latin America (LATAM) C-Reactive Protein Market, Revenues & Volume, By Detection Range, 2021 - 2031 |
8.5 Latin America (LATAM) C-Reactive Protein Market, Revenues & Volume, By Disease, 2021 - 2031 |
8.6 Latin America (LATAM) C-Reactive Protein Market, Revenues & Volume, By Analysis Mode, 2021 - 2031 |
8.7 Latin America (LATAM) C-Reactive Protein Market, Revenues & Volume, By End- User, 2021 - 2031 |
8.8 Latin America (LATAM) C-Reactive Protein Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9 Asia C-Reactive Protein Market, Overview & Analysis |
9.1 Asia C-Reactive Protein Market Revenues & Volume, 2021 - 2031 |
9.2 Asia C-Reactive Protein Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia C-Reactive Protein Market, Revenues & Volume, By Assay Type, 2021 - 2031 |
9.4 Asia C-Reactive Protein Market, Revenues & Volume, By Detection Range, 2021 - 2031 |
9.5 Asia C-Reactive Protein Market, Revenues & Volume, By Disease, 2021 - 2031 |
9.6 Asia C-Reactive Protein Market, Revenues & Volume, By Analysis Mode, 2021 - 2031 |
9.7 Asia C-Reactive Protein Market, Revenues & Volume, By End- User, 2021 - 2031 |
9.8 Asia C-Reactive Protein Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10 Africa C-Reactive Protein Market, Overview & Analysis |
10.1 Africa C-Reactive Protein Market Revenues & Volume, 2021 - 2031 |
10.2 Africa C-Reactive Protein Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa C-Reactive Protein Market, Revenues & Volume, By Assay Type, 2021 - 2031 |
10.4 Africa C-Reactive Protein Market, Revenues & Volume, By Detection Range, 2021 - 2031 |
10.5 Africa C-Reactive Protein Market, Revenues & Volume, By Disease, 2021 - 2031 |
10.6 Africa C-Reactive Protein Market, Revenues & Volume, By Analysis Mode, 2021 - 2031 |
10.7 Africa C-Reactive Protein Market, Revenues & Volume, By End- User, 2021 - 2031 |
10.8 Africa C-Reactive Protein Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11 Europe C-Reactive Protein Market, Overview & Analysis |
11.1 Europe C-Reactive Protein Market Revenues & Volume, 2021 - 2031 |
11.2 Europe C-Reactive Protein Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe C-Reactive Protein Market, Revenues & Volume, By Assay Type, 2021 - 2031 |
11.4 Europe C-Reactive Protein Market, Revenues & Volume, By Detection Range, 2021 - 2031 |
11.5 Europe C-Reactive Protein Market, Revenues & Volume, By Disease, 2021 - 2031 |
11.6 Europe C-Reactive Protein Market, Revenues & Volume, By Analysis Mode, 2021 - 2031 |
11.7 Europe C-Reactive Protein Market, Revenues & Volume, By End- User, 2021 - 2031 |
11.8 Europe C-Reactive Protein Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12 Middle East C-Reactive Protein Market, Overview & Analysis |
12.1 Middle East C-Reactive Protein Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East C-Reactive Protein Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey C-Reactive Protein Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East C-Reactive Protein Market, Revenues & Volume, By Assay Type, 2021 - 2031 |
12.4 Middle East C-Reactive Protein Market, Revenues & Volume, By Detection Range, 2021 - 2031 |
12.5 Middle East C-Reactive Protein Market, Revenues & Volume, By Disease, 2021 - 2031 |
12.6 Middle East C-Reactive Protein Market, Revenues & Volume, By Analysis Mode, 2021 - 2031 |
12.7 Middle East C-Reactive Protein Market, Revenues & Volume, By End- User, 2021 - 2031 |
12.8 Middle East C-Reactive Protein Market, Revenues & Volume, By Product Type, 2021 - 2031 |
13 Global C-Reactive Protein Market Key Performance Indicators |
14 Global C-Reactive Protein Market - Export/Import By Countries Assessment |
15 Global C-Reactive Protein Market - Opportunity Assessment |
15.1 Global C-Reactive Protein Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global C-Reactive Protein Market Opportunity Assessment, By Assay Type, 2021 & 2031F |
15.3 Global C-Reactive Protein Market Opportunity Assessment, By Detection Range, 2021 & 2031F |
15.4 Global C-Reactive Protein Market Opportunity Assessment, By Disease, 2021 & 2031F |
15.5 Global C-Reactive Protein Market Opportunity Assessment, By Analysis Mode, 2021 & 2031F |
15.6 Global C-Reactive Protein Market Opportunity Assessment, By End- User, 2021 & 2031F |
15.7 Global C-Reactive Protein Market Opportunity Assessment, By Product Type, 2021 & 2031F |
16 Global C-Reactive Protein Market - Competitive Landscape |
16.1 Global C-Reactive Protein Market Revenue Share, By Companies, 2024 |
16.2 Global C-Reactive Protein Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |